Clinical features | Patients (N = 73) | 5-year survival (%) | P | |
---|---|---|---|---|
patients | Rate (%) | |||
Gender | 0.711 | |||
Male | 66 | 26 | 39.4 | |
Female | 7 | 3 | 42.9 | |
Age | 0.451 | |||
< 60 | 23 | 10 | 43.5 | |
≥ 60 | 50 | 19 | 38.0 | |
Differentiation | 0.928 | |||
Good | 3 | 2 | 66.7 | |
Moderate | 53 | 21 | 39.6 | |
Poor | 17 | 6 | 35.3 | |
pT classification | 0.465 | |||
pT1 | 12 | 6 | 50.0 | |
pT2 | 32 | 13 | 40.6 | |
pT3 | 29 | 10 | 34.5 | |
pN | 0.001 | |||
− | 27 | 19 | 70.4 | |
+ | 46 | 10 | 21.7 | |
pTNM stage | 0.001 | |||
pI | 12 | 9 | 75.0 | |
pII | 30 | 15 | 50.0 | |
pIIIa | 31 | 5 | 16.1 | |
YTHDF2 expression | 0.002 | |||
Low | 29 | 16 | 55.2 | |
High | 44 | 13 | 29.5 |